Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 0.52% today. In the last week its performance is 1.44%, and 22.87% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 340.33, so today’s gain of 0.52% is a significant step towards its target price. The GAP today is therefore -0.23%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 68424.93, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.30%.
At the current price of 312.3, it has a dividend yield of *TBA, and its target price is 340.33. This is with a profit margin of 34.00%, and total debt/equity of 0.57. Biogen Inc. (NASDAQ:BIIB) has a P/E of 18.23, as well as a forward P/E of 15.02.
With a current EPS of 17.13, and a forecasted EPS growth for next year at 3.38%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 9.50%.
Performance for the year is 1.15%. Since its IPO date on 9/17/1991, the total performance to date is 1.94%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 1154200, while its average volume is 1955.55. Whilst the total gain today was 0.52%, it did have a day high of -6.40%.
Volatility for this week has been at 1.95%, and 1.98% for the month. The 52-week low for Biogen Inc., BIIB has been 40.03%, while the 52-week-high has reached -6.40%.
Looking at its return of investments, which is 23.50%, and its return on assets is 18.50%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.90%. With a sales growth of 11.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 3 and 2.6 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 1.92, and the P/S is 6.09, along with a P/B of 6. Meanwhile it has a p/cash of 18.02.